Health Care & Life Sciences » Biotechnology | Vitrolife AB

Vitrolife AB | Income Statement

Fiscal year is January-December. All values SEK Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
453
511
722
856
1,046
1,151
Cost of Goods Sold (COGS) incl. D&A
165
172
248
302
371
380
Gross Income
287
339
474
554
675
772
SG&A Expense
201
204
258
293
332
366
EBIT
87
135
216
260
343
406
Unusual Expense
-
9
1
8
13
16
Non Operating Income/Expense
4
13
19
2
2
8
Interest Expense
-
2
1
1
1
1
Pretax Income
80
147
227
249
341
399
Income Tax
23
37
43
58
76
88
Consolidated Net Income
57
109
183
191
265
311
Net Income
56
109
183
190
264
310
Net Income After Extraordinaries
56
109
183
190
264
310
Net Income Available to Common
56
109
183
190
264
310
EPS (Basic)
0.57
1.09
1.68
1.75
2.43
2.85
Basic Shares Outstanding
99
100
109
109
109
109
EPS (Diluted)
0.57
1.09
1.68
1.75
2.43
2.85
Diluted Shares Outstanding
99
100
109
109
109
109
EBITDA
108
156
269
314
410
457
Non-Operating Interest Income
-
-
-
-
-
1
Minority Interest Expense
-
-
1
1
1
1

About Vitrolife AB

View Profile
Address
Gustaf Werners Gata 2
Gothenburg VG 421 32
Sweden
Employees -
Website http://www.vitrolife.com
Updated 07/08/2019
Vitrolife AB engages in the development, manufacture, and sale of products and systems for the preparation, cultivation, and storage of human cells, tissue, and organs. It operates through the following geographical segments: EMEA, North and South America, and Asia & Pacific. Its products include FertiRoof, Vitrification, Slow freezing, OVOIL-culture oil, and Follicle aspiration needles.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.